Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The BioIndustry Association

The UK BioIndustry Association, the BIA, is the trade association for innovative enterprises involved in UK bioscience. Members include start-up, emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

The BioIndustry Association
7th Floor, Southside, 105 Victoria Street, London, SW1E 6QT
+44 (0)20 7630 2180
Contact The BioIndustry Association
Website

 Latest Content from PMHub 

Pharma need to keep their ‘pull & push’ separate from their ‘inbound & outbound’

White Papers and Resources | August 8, 2017 | An agency called Owen

Is your pharma brand using the marketing terms ‘pull & push’ correctly?

A man walks into a surgery: The role of storytelling in pharma marketing

White Papers and Resources | August 4, 2017 | Life Healthcare Communications

Communicating through stories can make your brand messages more meaningful, memorable and persuasive

Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich

White Papers and Resources | August 3, 2017 | Say Communications

Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...

The Art of Agile Marketing

White Papers and Resources | August 3, 2017 | Anthill Agency

The industry knows that it needs become more responsive to its stakeholders. An agile approach – which quickly improves results through a process of rapid market feedback and response –...

Could ketamine be the next big thing in depression?

White Papers and Resources | August 3, 2017 | Blue Latitude Health

Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

Attracting doctors to low-demand specialties: A role for industry?

White Papers and Resources | August 3, 2017 | Porterhouse Medical Group

 One of the major problems that healthcare systems around the world face is a paucity of medically qualified staff entering particular specialties and subspecialties. This can be due to a...

Men vs Women in emerging markets

White Papers and Resources | August 2, 2017 | Inizio

Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS

South Korea: The next global player?

White Papers and Resources | August 2, 2017 | Inizio

In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two...

20 questions: Round 4

White Papers and Resources | August 2, 2017 | Inizio

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What’s been the funniest thing to happen to you whilst you’ve...

Will gene therapies finally be commercially viable to pharma?

White Papers and Resources | August 2, 2017 | Inizio

Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when...